JPMorgan Chase & Co’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,494,183
Closed -$26.9M 5229
2020
Q2
$26.9M Buy
1,494,183
+1,442,634
+2,799% +$26M 0.01% 1090
2020
Q1
$367K Sell
51,549
-117,208
-69% -$834K ﹤0.01% 3438
2019
Q4
$4.03M Buy
168,757
+120,256
+248% +$2.87M ﹤0.01% 2301
2019
Q3
$1.3M Sell
48,501
-619,731
-93% -$16.6M ﹤0.01% 2944
2019
Q2
$17.8M Sell
668,232
-552,553
-45% -$14.7M ﹤0.01% 1415
2019
Q1
$42.4M Buy
1,220,785
+500,330
+69% +$17.4M 0.01% 929
2018
Q4
$14.1M Buy
720,455
+34,376
+5% +$671K ﹤0.01% 1472
2018
Q3
$18.3M Buy
686,079
+65,190
+10% +$1.74M ﹤0.01% 1488
2018
Q2
$23.5M Sell
620,889
-49,385
-7% -$1.87M ﹤0.01% 1287
2018
Q1
$21.9M Buy
670,274
+20,010
+3% +$654K ﹤0.01% 1305
2017
Q4
$31.7M Sell
650,264
-94,438
-13% -$4.6M 0.01% 1105
2017
Q3
$40.1M Buy
744,702
+26,544
+4% +$1.43M 0.01% 958
2017
Q2
$40.3M Sell
718,158
-346,034
-33% -$19.4M 0.01% 938
2017
Q1
$41.7M Sell
1,064,192
-181,728
-15% -$7.12M 0.01% 921
2016
Q4
$28M Sell
1,245,920
-18,235
-1% -$409K 0.01% 1109
2016
Q3
$28.7M Sell
1,264,155
-48,033
-4% -$1.09M 0.01% 1030
2016
Q2
$31M Buy
1,312,188
+14,072
+1% +$332K 0.01% 979
2016
Q1
$26.5M Buy
1,298,116
+526,817
+68% +$10.7M 0.01% 1045
2015
Q4
$39.7M Sell
771,299
-149,106
-16% -$7.67M 0.01% 836
2015
Q3
$39.2M Sell
920,405
-5,721
-0.6% -$244K 0.01% 831
2015
Q2
$42.2M Sell
926,126
-21,212
-2% -$966K 0.01% 896
2015
Q1
$36M Sell
947,338
-126,872
-12% -$4.82M 0.01% 986
2014
Q4
$30.4M Sell
1,074,210
-155,386
-13% -$4.4M 0.01% 1075
2014
Q3
$31.1M Sell
1,229,596
-88,957
-7% -$2.25M 0.01% 1047
2014
Q2
$38.5M Sell
1,318,553
-23,203
-2% -$677K 0.01% 967
2014
Q1
$34.8M Buy
1,341,756
+300,323
+29% +$7.78M 0.01% 989
2013
Q4
$26.8M Buy
+1,041,433
New +$26.8M 0.01% 1097